PHARMA & DISTRIBUTION

Pharmaceutical Distribution Channel Study

Pharma distribution heads, trade marketing leads, and channel strategy teams evaluate, compare, and navigate stockist reach, distributor margins, and last-mile fill rates, so you can fix channel mix, sharpen pricing structures, and convert underperforming territories.

Pan-India sample
Pharma distributors (Channel Decision-Makers)
15-20 min
Talk to a Survey Consultant
Channel conversion gapsIdentify where stockists stall, switch suppliers, or reduce order frequency.
Margin pressure & trade-offsBenchmark distributor margin expectations against actual channel performance signals.
TRUSTED BY LEADING BRANDS
Brand 0Brand 1Brand 2Brand 3Brand 4Brand 5Brand 6Brand 7Brand 8Brand 9Brand 10Brand 11Brand 12Brand 13Brand 14Brand 15Brand 16Brand 17Brand 18Brand 19Brand 20Brand 21Brand 22Brand 23Brand 24Brand 25Brand 26Brand 27Brand 28Brand 29Brand 30Brand 31

CONTEXT & RELEVANCE

Why run this survey now

Most pharma distribution heads don't lose channel margin purely on wholesaler pricing. They lose it due to stockist loyalty gaps, chemist push incentive misalignment, C&F agent inefficiencies, last-mile fill-rate failures, and distributor conflict across trade tiers, none of which fully show up in secondary sales reports or ERP dispatch data.

If you are...

  • National distribution head, branded generics
  • Trade channel vs direct-to-chemist debate
  • Stockist network restructuring teams
  • Pharma GTM or revenue planning lead
  • Corporate strategy, channel expansion mandate

You're likely facing...

  • Stockist loyalty: branded vs generic conflict
  • Fill-rate gaps at last-mile chemist
  • C&F cost vs service trade-off
  • Push incentive misalignment across tiers
  • Channel switching at distributor renewal

This will help answer...

  • Stockist preference drivers beyond margin
  • Fill-rate drop-off tier and stage
  • Segment split: trade vs direct channel
  • Incentive structure vs switching threshold
  • Distributor retention and renewal triggers

RESEARCH THEMES

What This Survey Investigates

Eight interconnected research themes that map the complete pharmaceutical distribution journey from manufacturer dispatch to dispensing point.

TENETS 01

Channel Structure & Reach

  • Stockist-to-retailer tier depth
  • Sub-stockist coverage gaps
TENETS 02

Stockist Selection Drivers

  • Criteria for appointing new stockists
  • Credit history, geography, brand alignment
TENETS 03

Order & Fulfilment Flow

  • Order placement method, cycle frequency
  • Fulfilment lead time by channel
TENETS 04

Margin & Trade Terms

  • Stockist margin bands by category
  • Scheme frequency, PTR-to-MRP spread
TENETS 05

Credit & Working Capital

  • Credit period norms, overdue exposure
  • Working capital strain by season
TENETS 06

Cold Chain & Compliance

  • Cold storage capacity, temperature breach frequency
  • Schedule H, H1 handling practices
TENETS 07

Digital Adoption & Tools

  • DMS, ERP, e-pharmacy platform usage
  • Barriers to digital order management
TENETS 08

Supplier Loyalty & Switching

  • MR visit frequency, brand support quality
  • Switching triggers by molecule category

SAMPLING STRATEGY

Tell us about your ideal sample

Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.

Sample size
How many respondents do you need?
Not Selected
Target audience
Who should we survey?
Not Selected
Region
Which regions should we cover?
Not Selected
Segments
How should we slice the data?
Not Selected
Discuss sample plan

METHODOLOGY

Survey approach

For the Pharmaceutical Distribution Channel Study, we recommend a quant-first design with flexible data-collection modes to balance reach, depth, and verification across distributor, stockist, and retail pharmacy tiers.

PRIMARY
Online web surveySelf-administered survey shared via email / panels to capture structured responses at scale.
Best for
1
Ranking channel preference across distributor tiers
2
Measuring margin satisfaction by product category
3
Comparing stockist reach by geography and molecule type
Deliverables
Channel preference ranking
Margin gap matrix
Territory coverage map
OPTIONAL
CATI (phone survey)Interviewer-led telephone interviews to reach owners who are harder to get online.
Best for
1
Semi-urban stockists with low digital adoption
2
Quick pulse across Tier 2 and Tier 3 markets
Deliverables
Stockist coverage data
Call-log diagnostics
SELECTIVE
Face-to-faceOn-ground surveys or interviews in key industrial clusters or high-value cohorts.
Best for
1
Super-stockists and C&F agents in key pharma hubs
2
High-volume retail pharmacy chains needing in-depth verification
Deliverables
Cluster channel insights
Distributor journey maps
OPTIONAL
FGDs
Deliverables
Themes and verbatims
Incentive concept feedback
OPTIONAL
Mixed surveysAny 4-mode combo Online + CATI + F2F + FGDs to maximise reach and representation. Mode-specific quotas and weighting for clean comparisons.
Deliverables
Unified dataset
Mode-adjusted analytics
Our Recommendation
Start with: Online web survey as the core quant layer, targeting distributors, stockists, and retail pharmacy owners across urban and semi-urban geographies, supported by CATI for Tier 2 and Tier 3 markets with low digital penetration.
Consider adding: F2F interviews for super-stockists and C&F agents in high-volume pharma distribution hubs, plus a focused FGD layer to pressure-test channel incentive structures and identify conflict points between field sales and distributor networks.

EXECUTION PROCESS

How we execute

A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.

Define the decision frame

Confirm objectives, target cohorts, geographies, and reporting cuts

Step 01

Define the decision frame

Design the instrument

Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)

Step 02

Design the instrument

Lock the questionnaire

Review wording, sequencing, LOI, and competitive context; approve final version

Step 03

Lock the questionnaire

Pilot and calibrate

Test comprehension and ease quality; refine quotas and remove friction where needed

Step 04

Pilot and calibrate

Run fieldwork

Execute collection with active quota management and feasibility controls

Step 05

Run fieldwork

Assure quality

Dedupe, attention checks, speed/consistency rules, removals with audit trail

Step 06

Assure quality

Prepare the dataset

Clean data and deliver codebook/variable definitions

Step 07

Prepare the dataset

Analyse and synthesise

Driver ranking, leakage diagnostics, pricing bands, segment insights

Step 08

Analyse and synthesise

Deliver and align

Executive deck (optional dashboard) and leadership readout with recommendations

Step 09

Deliver and align

COMMERCIAL TERMS

Request a Commercial Proposal

Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.

Select Sample Size

100

Geography

  • India
  • APAC (Singapore, Vietnam, Philippines, Indonesia, Australia, NZ, Japan, Thailand)
  • Middle East (UAE, KSA, Qatar, Bahrain, Oman, Kuwait)
  • North America (US, Canada)
  • Europe
  • Africa (South Africa, Kenya, Nigeria, Egypt, Algeria)
  • LATAM (Brazil, Mexico)

Select Mode of Survey

  • Online
  • CATI
  • Online FGD (5 people per FGD)
  • F2F

Length of the Interview

  • Select
  • 0-15
  • 16-20
  • 21-30
  • 31-45
  • 46-60
  • Custom
Indicative Estimate
  • Indian Rupee (INR)
  • United Arab Emirates Dirham (AED)
  • Afghan Afghani (AFN)
  • Albanian Lek (ALL)
  • Armenian Dram (AMD)
  • Netherlands Antillean Guilder (ANG)
  • Angolan Kwanza (AOA)
  • Argentine Peso (ARS)
  • Australian Dollar (AUD)
  • Aruban Florin (AWG)
  • Azerbaijani Manat (AZN)
  • Bosnia-Herzegovina Convertible Mark (BAM)
  • Barbadian Dollar (BBD)
  • Bangladeshi Taka (BDT)
  • Bulgarian Lev (BGN)
  • Bahraini Dinar (BHD)
  • Burundian Franc (BIF)
  • Bermudian Dollar (BMD)
  • Brunei Dollar (BND)
  • Bolivian Boliviano (BOB)
  • Brazilian Real (BRL)
  • Bahamian Dollar (BSD)
  • Bhutanese Ngultrum (BTN)
  • Botswana Pula (BWP)
  • Belarusian Ruble (BYN)
  • Belize Dollar (BZD)
  • Canadian Dollar (CAD)
  • Congolese Franc (CDF)
  • Swiss Franc (CHF)
  • Chilean Peso (CLP)
  • Chinese Yuan (CNY)
  • Colombian Peso (COP)
  • Costa Rican Colón (CRC)
  • Cuban Peso (CUP)
  • Cape Verdean Escudo (CVE)
  • Czech Koruna (CZK)
  • Djiboutian Franc (DJF)
  • Danish Krone (DKK)
  • Dominican Peso (DOP)
  • Algerian Dinar (DZD)
  • Egyptian Pound (EGP)
  • Eritrean Nakfa (ERN)
  • Ethiopian Birr (ETB)
  • Euro (EUR)
  • Fijian Dollar (FJD)
  • Falkland Islands Pound (FKP)
  • British Pound (GBP)
  • Georgian Lari (GEL)
  • Ghanaian Cedi (GHS)
  • Gibraltar Pound (GIP)
  • Gambian Dalasi (GMD)
  • Guinean Franc (GNF)
  • Guatemalan Quetzal (GTQ)
  • Guyanese Dollar (GYD)
  • Hong Kong Dollar (HKD)
  • Honduran Lempira (HNL)
  • Croatian Kuna (HRK)
  • Haitian Gourde (HTG)
  • Hungarian Forint (HUF)
  • Indonesian Rupiah (IDR)
  • Israeli New Shekel (ILS)
  • Iraqi Dinar (IQD)
  • Iranian Rial (IRR)
  • Icelandic Króna (ISK)
  • Jamaican Dollar (JMD)
  • Jordanian Dinar (JOD)
  • Japanese Yen (JPY)
  • Kenyan Shilling (KES)
  • Kyrgyzstani Som (KGS)
  • Cambodian Riel (KHR)
  • Comorian Franc (KMF)
  • South Korean Won (KRW)
  • Kuwaiti Dinar (KWD)
  • Cayman Islands Dollar (KYD)
  • Kazakhstani Tenge (KZT)
  • Lao Kip (LAK)
  • Lebanese Pound (LBP)
  • Sri Lankan Rupee (LKR)
  • Liberian Dollar (LRD)
  • Lesotho Loti (LSL)
  • Libyan Dinar (LYD)
  • Moroccan Dirham (MAD)
  • Moldovan Leu (MDL)
  • Malagasy Ariary (MGA)
  • Macedonian Denar (MKD)
  • Burmese Kyat (MMK)
  • Mongolian Tögrög (MNT)
  • Macanese Pataca (MOP)
  • Mauritian Rupee (MUR)
  • Maldivian Rufiyaa (MVR)
  • Malawian Kwacha (MWK)
  • Mexican Peso (MXN)
  • Malaysian Ringgit (MYR)
  • Mozambican Metical (MZN)
  • Namibian Dollar (NAD)
  • Nigerian Naira (NGN)
  • Nicaraguan Córdoba (NIO)
  • Norwegian Krone (NOK)
  • Nepalese Rupee (NPR)
  • New Zealand Dollar (NZD)
  • Omani Rial (OMR)
  • Panamanian Balboa (PAB)
  • Peruvian Sol (PEN)
  • Papua New Guinean Kina (PGK)
  • Philippine Peso (PHP)
  • Pakistani Rupee (PKR)
  • Polish Złoty (PLN)
  • Paraguayan Guaraní (PYG)
  • Qatari Riyal (QAR)
  • Romanian Leu (RON)
  • Serbian Dinar (RSD)
  • Russian Ruble (RUB)
  • Rwandan Franc (RWF)
  • Saudi Riyal (SAR)
  • Solomon Islands Dollar (SBD)
  • Seychellois Rupee (SCR)
  • Sudanese Pound (SDG)
  • Swedish Krona (SEK)
  • Singapore Dollar (SGD)
  • Saint Helena Pound (SHP)
  • Sierra Leonean Leone (SLL)
  • Somali Shilling (SOS)
  • Surinamese Dollar (SRD)
  • São Tomé and Príncipe Dobra (STD)
  • Syrian Pound (SYP)
  • Swazi Lilangeni (SZL)
  • Thai Baht (THB)
  • Tajikistani Somoni (TJS)
  • Turkmenistani Manat (TMT)
  • Tunisian Dinar (TND)
  • Tongan Paʻanga (TOP)
  • Turkish Lira (TRY)
  • Trinidad and Tobago Dollar (TTD)
  • New Taiwan Dollar (TWD)
  • Tanzanian Shilling (TZS)
  • Ukrainian Hryvnia (UAH)
  • Ugandan Shilling (UGX)
  • United States Dollar (USD)
  • Uruguayan Peso (UYU)
  • Uzbekistani Som (UZS)
  • Vietnamese Đồng (VND)
  • Vanuatu Vatu (VUV)
  • Samoan Tālā (WST)
  • Central African CFA Franc (XAF)
  • East Caribbean Dollar (XCD)
  • West African CFA franc (XOF)
  • CFP Franc (XPF)
  • Yemeni Rial (YER)
  • South African Rand (ZAR)
  • Zambian Kwacha (ZMW)
  • Zimbabwean Dollar (ZWL)

$0.00

+ applicable taxes

Proposal turnaround typically 24–48 hours

Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.

REFERENCE CASELETS

Reference

Real-world examples of survey work in the pharmaceutical distribution space.

CASELET 1

Stockist loyalty & channel switching triggers in generic pharma (India)

CASELET 2

Chemist prescription fulfilment behaviour & brand substitution (West India)

Stockist loyalty & channel switching triggers in generic pharma (India)

OBJECTIVE

A mid-size generic pharmaceutical manufacturer needed to quantify why Class A and Class B stockists shift primary supplier allegiance, and which credit terms, margin structures, and return policies most strongly predict retention versus defection.

WHAT WE DID

Ran a structured quant survey across 320 stockists in 6 states, capturing supplier shortlist composition, primary order frequency, credit cycle length, return claim turnaround, and stated switching intent by product category and distributor tier.

DELIVERED

A stockist loyalty segmentation framework , a ranked list of channel retention levers by tier, a margin sensitivity corridor by geography, and a switching trigger map identifying the 4 conditions most predictive of supplier defection.
CASELET 1

Stockist loyalty & channel switching triggers in generic pharma (India)

CASELET 2

Chemist prescription fulfilment behaviour & brand substitution (West India)

Stockist loyalty & channel switching triggers in generic pharma (India)

OBJECTIVE

A mid-size generic pharmaceutical manufacturer needed to quantify why Class A and Class B stockists shift primary supplier allegiance, and which credit terms, margin structures, and return policies most strongly predict retention versus defection.

WHAT WE DID

Ran a structured quant survey across 320 stockists in 6 states, capturing supplier shortlist composition, primary order frequency, credit cycle length, return claim turnaround, and stated switching intent by product category and distributor tier.

DELIVERED

A stockist loyalty segmentation framework , a ranked list of channel retention levers by tier, a margin sensitivity corridor by geography, and a switching trigger map identifying the 4 conditions most predictive of supplier defection.

FREQUENTLY ASKED QUESTIONS

Common Questions

Answers to frequently asked questions about this survey mandate.

What decisions will this survey enable?

Who is the buyer vs who are the respondents?

Can we see differences between stockist-led, direct-to-pharmacy and hospital supply chain channels?

How will you measure channel partner preference beyond simple ratings?

Will the survey map the full pharmaceutical distribution journey and drop-offs?

Can this survey inform product and pricing strategy?

How will findings improve our channel expansion and trade marketing ROI?

Still have questions?

Schedule a discovery call to discuss your specific needs and get a custom quote.

Book a Discovery Call